NEW YORK (GenomeWeb) – Qiagen said in a filing with the US Securities and Exchange Commission today that it paid $114.2 million in cash consideration to acquire Enzymatics' enzyme solutions unit in December 2014.

The firm said that $11.5 million was retained in an escrow account to cover any claims for breach of any representations, warranties, or indemnities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.